Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46,005 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ultra-High Dose Rate FLASH Irradiation Induced Radio-Resistance of Normal Fibroblast Cells Can Be Enhanced by Hypoxia and Mitochondrial Dysfunction Resulting From Loss of Cytochrome C.
Han J, Mei Z, Lu C, Qian J, Liang Y, Sun X, Pan Z, Kong D, Xu S, Liu Z, Gao Y, Qi G, Shou Y, Chen S, Cao Z, Zhao Y, Lin C, Zhao Y, Geng Y, Chen J, Yan X, Ma W, Yang G. Han J, et al. Among authors: lin c. Front Cell Dev Biol. 2021 Apr 30;9:672929. doi: 10.3389/fcell.2021.672929. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33996831 Free PMC article.
Association of Cancer Stem Cell Radio-Resistance Under Ultra-High Dose Rate FLASH Irradiation With Lysosome-Mediated Autophagy.
Yang G, Lu C, Mei Z, Sun X, Han J, Qian J, Liang Y, Pan Z, Kong D, Xu S, Liu Z, Gao Y, Qi G, Shou Y, Chen S, Cao Z, Zhao Y, Lin C, Zhao Y, Geng Y, Ma W, Yan X. Yang G, et al. Among authors: lin c. Front Cell Dev Biol. 2021 Apr 29;9:672693. doi: 10.3389/fcell.2021.672693. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33996830 Free PMC article.
Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events.
Khattab S, Wan G, Xu S, Moseley C, Tran M, Beagles E, Lin C, Leung B, Azin M, Hao N, Reynolds KL, Demehri S, LeBoeuf NR, Semenov YR. Khattab S, et al. Among authors: lin c. medRxiv [Preprint]. 2025 Jan 8:2025.01.07.25320156. doi: 10.1101/2025.01.07.25320156. medRxiv. 2025. PMID: 39830283 Free PMC article. Preprint.
Real-world efficacy and safety of universal 8-week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre-end-stage renal disease: Insights from a nationwide hepatisis C virus registry in Taiwan.
Wang SJ, Huang CF, Chang TS, Lo CC, Hung CH, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Kuo HT, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Tseng KC, Chen CY, Wang SC, Yu ML. Wang SJ, et al. Among authors: lin cl. Kaohsiung J Med Sci. 2025 Jan 19:e12929. doi: 10.1002/kjm2.12929. Online ahead of print. Kaohsiung J Med Sci. 2025. PMID: 39829106
46,005 results
You have reached the last available page of results. Please see the User Guide for more information.